Igor Yellson

Doctor of Medicine,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Sales and Marketing Pharma-CRO-Device

Areas Of Interest

Traumatic Amputation HSC73 Protein Verbal Fluency Disorders Myopathies, X-Linked Centronuclear Intestinal Pseudoobstruction Secretases Oral Leukoedemas Lymphocytoses, Familial Hemophagocytic Thiol-Specific Antioxidant Protein Glucuronate, Methylazoxymethanol Hypofractionations, Radiotherapy Dose Psychotherapeutic Imagery Infection, Coronavirus Colonic Diverticulosis Motion Measures, Outcome Alkaline Phosphodiesterase I Interleukin 3 Receptor alpha Subunit Inosinic Acids Drinking, Binge Fragility, Chromosome CXADR-Like Membrane Protein Crop, Avian Malfunction, Equipment Primary Biliary Cholangitides

Professional Narrative

Dr. Igor Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 1991
Executive Director, Amgen 1987

Education

Director Medicine, Harvard Medical School 2009
Doctor of medicine, Harvard Medical School 2017

Referees


Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :